Nitrosamine Impurities in Pharmaceutical Drug Substances and Drug Products: Risk Assessment, Analytical Validation, Regulatory Guidance, and Lifecycle Management | AMiner
Nitrosamine Impurities in Pharmaceutical Drug Substances and Drug Products: Risk Assessment, Analytical Validation, Regulatory Guidance, and Lifecycle Management
原文链接
分享
引用
